VinsBio was established in the year 1997. Their commercial production began in the year 2001 with snake venom antiserum. They were awarded Prarisramika Vijetha title in the year 2003. In 2004, Antirabies Serum was launched. In the year 2005, Tetanus Antitoxin was introduced followed by Diphtheria Antitoxin in 2006. African 10 antivenom was launched in liquid form in 2007 and Central African Antivenom in 2008. In 2009, Mixed Gas Gangrene Antitoxin was taken up at R & D scale.Tetanus antitoxin was also launched in pre-filled syringe form. Scorpion Antivenom was added in 2010 along with trivalent snake venom antitoxin for the Middle East and North African countries.

Three Monovalent snake antivenoms against Cobra, Viper and Echis snakes were launched in 2011.Ampoule manufacturing line was included along with the vial manufacturing line in 2012. A new facility for the small animal testing lab was constructed in 2013 to meet GLP requirements. The antithymocyte globulin was taken up for R & D in 2014. Mixed Gas Gangrene Antitoxin was approved by regulatory authority for the commercial launch in 2015.]

Vision

VINS brings to the world life saving bio-pharmaceutical and biological products. It delivers value and satisfaction to its customers and stakeholders.

Mission

• To ensure state-of-the-art manufacturing capabilities.
• To maintain internationally benchmarked quality and regulatory systems.
• To augment the human resource development system through training, monitoring, leadership & empowerment.
• To enhance customer relationships by offering outstanding products and services.
• To implement research and business partnership management.
• To extend strong and visible support for the quality system, thereby ensuring its implementation throughout the organization.
• To ensure high quality standards across all products; not just the product meant for testing alone.